These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34272158)

  • 1. COVID-19 and acute exacerbation of interstitial lung disease.
    Kondoh Y; Kataoka K; Ando M; Awaya Y; Ichikado K; Kataoka M; Komase Y; Mineshita M; Ohno Y; Okamoto H; Ooki T; Tasaka Y; Tomioka H; Suda T
    Respir Investig; 2021 Sep; 59(5):675-678. PubMed ID: 34272158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of acute exacerbation in patients with interstitial lung disease after COVID-19 vaccination.
    Sakayori M; Hagiwara E; Baba T; Kitamura H; Sekine A; Ikeda S; Tabata E; Yamada S; Fujimoto K; Ogura T
    J Infect Chemother; 2023 Jan; 29(1):105-108. PubMed ID: 36113847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
    Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
    Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
    Singh P; Thakur B; Mohapatra AK; Padhan P
    Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute exacerbation of interstitial lung disease after procedures.
    Amundson WH; Racila E; Allen T; Dincer HE; Tomic R; Bhargava M; Perlman DM; Kim HJ
    Respir Med; 2019 Apr; 150():30-37. PubMed ID: 30961948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases.
    Salonen J; Vähänikkilä H; Purokivi M; Kaarteenaho R
    PLoS One; 2020; 15(11):e0242860. PubMed ID: 33253258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.
    Ishikawa G; Acquah SO; Salvatore M; Padilla ML
    Respir Med; 2017 Jul; 128():78-84. PubMed ID: 28610674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-hospitalisation predicts poor prognosis after acute exacerbation of interstitial lung disease.
    Salonen J; Jansa S; Vähänikkilä H; Kaarteenaho R
    BMC Pulm Med; 2023 Jul; 23(1):236. PubMed ID: 37393286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study.
    Drake TM; Docherty AB; Harrison EM; Quint JK; Adamali H; Agnew S; Babu S; Barber CM; Barratt S; Bendstrup E; Bianchi S; Villegas DC; Chaudhuri N; Chua F; Coker R; Chang W; Crawshaw A; Crowley LE; Dosanjh D; Fiddler CA; Forrest IA; George PM; Gibbons MA; Groom K; Haney S; Hart SP; Heiden E; Henry M; Ho LP; Hoyles RK; Hutchinson J; Hurley K; Jones M; Jones S; Kokosi M; Kreuter M; MacKay LS; Mahendran S; Margaritopoulos G; Molina-Molina M; Molyneaux PL; O'Brien A; O'Reilly K; Packham A; Parfrey H; Poletti V; Porter JC; Renzoni E; Rivera-Ortega P; Russell AM; Saini G; Spencer LG; Stella GM; Stone H; Sturney S; Thickett D; Thillai M; Wallis T; Ward K; Wells AU; West A; Wickremasinghe M; Woodhead F; Hearson G; Howard L; Baillie JK; Openshaw PJM; Semple MG; Stewart I; Jenkins RG;
    Am J Respir Crit Care Med; 2020 Dec; 202(12):1656-1665. PubMed ID: 33007173
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
    Hozumi H; Kono M; Hasegawa H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
    Chest; 2021 Jun; 159(6):2334-2345. PubMed ID: 33571506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung transplantation for acute exacerbation of interstitial lung disease.
    Chizinga M; Machuca TN; Shahmohammadi A; Patel DC; Innabi A; Alzghoul B; Scheuble V; Pipkin M; Mehrad B; Pelaez A; Lin C; Gomez-Manjarres D
    Thorax; 2022 Apr; 77(4):364-369. PubMed ID: 34226204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: clinical features and prognosis.
    Izuka S; Yamashita H; Iba A; Takahashi Y; Kaneko H
    Rheumatology (Oxford); 2021 May; 60(5):2348-2354. PubMed ID: 33241299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia.
    Manfredi A; Luppi F; Cassone G; Vacchi C; Salvarani C; Sebastiani M
    Expert Rev Clin Immunol; 2020 Aug; 16(8):751-770. PubMed ID: 32722946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease].
    Huang C; Ma C; Wu Q; Jiao P; Sun Y; Tian W; Yu H; Huang W; Wang Y; Tong H
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):343-350. PubMed ID: 32429636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery.
    Takao S; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Medicine (Baltimore); 2019 Feb; 98(5):e14296. PubMed ID: 30702600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide survey of radiation therapy in Japan for lung cancer complicated with interstitial lung disease.
    Hagiwara Y; Nakayama Y; Kudo S; Hayakawa T; Nakamura N; Kitamoto Y; Takahashi S; Tsujino K; Kubo N; Tamaki Y; Nagata Y;
    J Radiat Res; 2020 Jul; 61(4):563-574. PubMed ID: 32363376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease during the SARS-CoV-2 pandemic.
    Shao C; Shi Y; Chen R; Liu X; Huang H; Zhao Y; Xu K; Chen K; Wang M; Xu Z
    J Med Virol; 2023 Sep; 95(9):e29098. PubMed ID: 37707416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and Outcomes of a Standardized Management Protocol for Acute Exacerbation of Interstitial Lung Disease.
    Adams CJ; Chohan K; Rozenberg D; Kavanagh J; Greyling G; Shapera S; Fisher JH
    Lung; 2021 Aug; 199(4):379-387. PubMed ID: 34347146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute exacerbation of interstitial lung disease associated with rheumatic disease.
    Luppi F; Sebastiani M; Salvarani C; Bendstrup E; Manfredi A
    Nat Rev Rheumatol; 2022 Feb; 18(2):85-96. PubMed ID: 34876670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.